KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsShares IssuedShort-Term Debt issuances
Ratios

Amneal Pharmaceuticals (AMRX) Receivables Refunds: 2018-2019

  • Amneal Pharmaceuticals' Receivables Refunds fell 53.62% to $13.7 million in Q4 2019 from the same period last year, while for Dec 2019 it was $13.7 million, marking a year-over-year decrease of 53.62%. This contributed to the annual value of $13.7 million for FY2019, which is 53.62% down from last year.
  • Latest data reveals that Amneal Pharmaceuticals reported Receivables Refunds of $13.7 million as of Q4 2019, which was down 53.62% from $29.6 million recorded in Q4 2018.
  • Amneal Pharmaceuticals' 5-year Receivables Refunds high stood at $29.6 million for Q4 2018, and its period low was $13.7 million during Q4 2019.
  • Its 2-year average for Receivables Refunds is $21.7 million, with a median of $21.7 million in 2018.
  • Data for Amneal Pharmaceuticals' Receivables Refunds shows a maximum YoY plummeted of 53.62% (in 2019) over the last 5 years.
  • Quarterly analysis of 2 years shows Amneal Pharmaceuticals' Receivables Refunds stood at $29.6 million in 2018, then crashed by 53.62% to $13.7 million in 2019.